Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Greenyn Biotechnology Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Greenyn Biotechnology Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.67.
Greenyn Biotechnology Co (ROCO:6846) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Greenyn Biotechnology Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Greenyn Biotechnology Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Greenyn Biotechnology Co Days Inventory Related Terms
Greenyn Biotechnology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6846 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Greenyn Biotechnology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenyn Biotechnology Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Greenyn Biotechnology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Greenyn Biotechnology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greenyn Biotechnology Co (ROCO:6846) has a Days Inventory of 118.90 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Greenyn Biotechnology Co and its competitors. This is 13% below median its historical median of 136.37. Over the past decade, Greenyn Biotechnology Co's Days Inventory has ranged from 120.94 to 164.17. According to the industry distribution chart, Greenyn Biotechnology Co ranks #226 out of 638 companies in the Biotechnology industry, placing it in the top 35.4%.
Is Greenyn Biotechnology Co's Days Inventory too high?
Greenyn Biotechnology Co's current Days Inventory of 118.90 is 13% below median its 10-year median of 136.37. Over the past 10 years, this metric has ranged from a low of 120.94 to a high of 164.17. The Biotechnology industry median Days Inventory is 183.20. Greenyn Biotechnology Co's value of 118.90 is 35.1% below this industry median. Based on the distribution chart, Greenyn Biotechnology Co ranks #226 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Greenyn Biotechnology Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Greenyn Biotechnology Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Greenyn Biotechnology Co ranks #226 out of 638 companies for Days Inventory. This puts Greenyn Biotechnology Co in the upper half of its industry. The industry median Days Inventory is 183.20. Greenyn Biotechnology Co's value of 118.90 is 35.1% below this benchmark. Historically, Greenyn Biotechnology Co's own Days Inventory has ranged from 120.94 to 164.17 over the past decade. While the company's 10-year median is 136.37 vs. the industry median of 183.20, Greenyn Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenyn Biotechnology Co's current Days Inventory of 118.90 is 35.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Greenyn Biotechnology Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenyn Biotechnology Co's current Days Inventory is 118.90, which is 13% below median its own 10-year median of 136.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenyn Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Greenyn Biotechnology Co (ROCO:6846) is currently considered Fairly Valued. The stock's GF Value™ is NT$66.75, compared to a current price of NT$62.90 — trading 5.8% below its estimated fair value. The current Days Inventory is 118.90, which is 13% below median its 10-year median of 136.37 and 35.1% below the Biotechnology industry median of 183.20. Greenyn Biotechnology Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Greenyn Biotechnology Co (ROCO:6846), the current Days Inventory is 118.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenyn Biotechnology Co (ROCO:6846) Overvalued in 2026?
Based on GuruFocus' analysis, Greenyn Biotechnology Co stock appears to be undervalued.
The current stock price of NT$62.90 is trading 5.8% below its estimated GF Value™ of NT$66.75.
GuruFocus considers Greenyn Biotechnology Co to be Fairly Valued.
Key valuation signals for ROCO:6846:
Days Inventory: 118.90 (13% below median its 10-year median of 136.37)
GF Value™: NT$66.75 vs. price of NT$62.90 (5.8% below fair value)
Industry Position: 35.1% below the Biotechnology median (#226 of 638)
No single metric tells the full story. See the ROCO:6846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenyn Biotechnology Co Ltd is engaged in the business of health food raw materials production and sales of raw materials and production and sales of formula preparation.
65GF Score
Get the complete analysis for ROCO:6846
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6846 has been successfully added to your 
